Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - roxithromycin - filmovertrukne tabletter - 150 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi pasteur europe - bordetella pertussis, filamentøs hæmagglutinin (fha), bordetella pertussis, toxoid, clostridium tetani, stamme harvard 49205, toxoid, corynebacterium diphtheria, stamme utrecht cn 2000 msm iii, toxoid, poliovirus type 1, stamme mahoney (inaktiveret), poliovirus type 2, stamme mef-1 (inaktiveret), poliovirus type 3, stamme saukett (inaktiveret) - injektionsvæske, suspension

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - natriumnedokromil - øjendråber - 20 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi pasteur europe - salmonella typhi ty2 vi kapselpolysaccharid - injektionsvæske, opløsning

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi pasteur europe - influenzavirus a/solomon islands/3/2006 (h1n1)-lign. st. (a/solomon islands/3/2006 (ivr-145)) inakt., influenzavirus a/wisconsin/67/2005 (h3n2)-lign.stamme(a/wisconsin/67/2005 (nymc x-161b)) inaktiveret, influenzavirus b/malaysia/2506/2004-lignende stamme (b/malaysia/2506/2004), inaktiveret - injektionsvæske, suspension, fyldt injektionssprøjte

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi pasteur europe - hepatitis a virus, stamme gbm (inaktiveret), salmonella typhi ty2 vi kapselpolysaccharid - opløsning og suspension til injektionsvæske, suspension, fyldt injektionssprøjte

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - alfuzosinhydrochlorid - filmovertrukne tabletter - 2,5 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influenza, human - vacciner - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi b.v. - avalglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomide - multipel sclerose - selektive immunosuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).